Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[CROATIAN GUIDELINES FOR THE PHARMACOTHERAPY OF TYPE 2 DIABETES].
Rahelić D, Altabas V, Bakula M, Balić S, Balint I, Marković BB, Bicanić N, Bjelinski I, Bozikov V, Varzić SC, Car N, Berković MC, Orlić ZC, Deskin M, Sunić ED, Tomić NG, Goldoni V, Gradiser M, Mahecić DH, Balen MJ, Erzen DJ, Majanović SK, Kokić' S, Krnic M, Kruljac I, Liberati-Cizmek AM, Martina L, Metelko Z, Mirosević G, Vrbica SM, Renar IP, Petric D, Prasek M, Prpić-Kizevać I, Radman M, Soldo D, Sarić T, Tesanović S, Kurir TT, Wensveen TT, Botica M, Vrkljan M, Rotkvic VZ, Zorić C, Krznarić Z. Rahelić D, et al. Among authors: goldoni v. Lijec Vjesn. 2016 Jan-Feb;138(1-2):1-21. Lijec Vjesn. 2016. PMID: 27443001 Croatian.
The role of insulin-related substance in Hodgkin's disease.
Cabrijan T, Levanat S, Pekić B, Pavelić J, Spaventi R, Frahm H, Zjacić-Rotkvić V, Goldoni V, Vrbanec D, Misjak M, et al. Cabrijan T, et al. Among authors: goldoni v. J Cancer Res Clin Oncol. 1991;117(6):615-9. doi: 10.1007/BF01613298. J Cancer Res Clin Oncol. 1991. PMID: 1744168
Concentration of glycogen in blood of diabetics.
Lutkić A, Cepo M, Dodiković V, Zjacić-Rotkvić V, Goldoni V, Mazuranić V, Cabrijan T, Cizmić A, Jurilj N. Lutkić A, et al. Among authors: goldoni v. Clin Investig. 1992 Aug;70(8):707. doi: 10.1007/BF00180293. Clin Investig. 1992. PMID: 1392451 No abstract available.
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE; EMPA-REG OUTCOME Investigators. Zinman B, et al. N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17. N Engl J Med. 2015. PMID: 26378978 Free article. Clinical Trial.
Basal insulin and cardiovascular and other outcomes in dysglycemia.
ORIGIN Trial Investigators; Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S. ORIGIN Trial Investigators, et al. N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858. Epub 2012 Jun 11. N Engl J Med. 2012. PMID: 22686416 Free article. Clinical Trial.
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.
ORIGIN Trial Investigators; Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S. ORIGIN Trial Investigators, et al. N Engl J Med. 2012 Jul 26;367(4):309-18. doi: 10.1056/NEJMoa1203859. Epub 2012 Jun 11. N Engl J Med. 2012. PMID: 22686415 Free article. Clinical Trial.
12 results